EMA recommends authorisation of Rasonque for metastatic pancreatic cancer
Imported from official source
EMA’s human medicines committee (CHMP) has recommended granting a marketing authorisation in the European Union for Rasonque (daraxonrasib), an oral treatment for adults with…
This version
- Version
- 1 of 1
- Recorded
- October 15, 2026 14:00
- Change
- Initial
- Content hash
75b50f5e1495a453fc5334451dc244f7- All versions
- Revision history